Rethinking PSA Testing: Navigating the Prostate Cancer Decision Zone

Rethinking PSA Testing: Navigating the Prostate Cancer Decision Zone

In this episode, Sidney Ocanagil-Tunstall is joined by Dr Asif Naseem, GP and specialist in preventative healthcare and men's health, alongside Dr Beat Rheiner, CEO of Proteomedix. Together, they discuss the role of PSA testing in current prostate cancer pathways, why many patients fall into a diagnostic “gray zone,” and how emerging approaches could improve early detection and reduce uncertainty for both clinicians and patients. The conversation explores the importance of personalised risk assessment, the impact of false positives and false negatives, and how new diagnostic tools may help identify clinically significant cancers earlier while supporting more efficient, patient-centred care.

Meet Techcyte’s CMO and uncover the pathologist-first approach to digital pathology

In this Thought Leaders episode, Sidney Ocanagil-Tunstall speaks with Dr. Tiffany Chen, Chief Medical Officer at Techcyte, about the realities of digital pathology adoption and what pathologists truly need from technology. The conversation explores workflow integration, AI in routine practice, trust in digital systems, and how Techcyte’s Fusion AP platform is designed to simplify increasingly complex pathology environments. Together, they discuss the future of pathology, where seamless workflows, interoperability, and pathologist-centred design are key to successful digital transformation.

AI, Clinical Trials & Companion Diagnostics: Eric Walk on the Future of Pathology

In this episode of the Pathology News podcast, Sidney Ocanagil-Tunstall speaks with Eric Walk about how AI-powered pathology tools are beginning to transform clinical diagnostics, pathology workflows, and precision medicine infrastructure. Eric discusses where AI is already delivering value in clinical practice, including case triage, workload balancing, biomarker quantification, quality control, and pathology workflow optimisation through PathAI’s AI Site DX platform. The conversation also explores the growing importance of trust, validation, and human oversight in AI-assisted diagnostics, alongside the ethical questions surrounding patient confidence and clinical decision-making. The episode further examines PathAI’s Precision Pathology Network (PPN), including how digitally mature pathology laboratories can collaborate with pharmaceutical companies through clinical trials, companion diagnostics, data licensing, and biomarker discovery programs. Rather than replacing pathologists, the discussion highlights how deep neural networks may elevate the profession, allowing pathologists to focus less on repetitive measurement tasks and more on precision medicine, therapy guidance, and integrated patient care.

The future of pathology with the ESDIP board and how to get involved with the organisation

Sidney Ocanagil-Tunstall, Marketing Director at Pathology News, returns for part 4 of the Pathology Bites series joined by ESDIP leaders Norman Zerbe, Vincenzo L’Imperio, and Inti Zlobec to explore the future of pathology and how professionals can become involved with the organisation and its growing international community. The discussion looks ahead at the next phase of digital and computational pathology, from the wider adoption of digital workflows and AI-powered biomarkers to the growing role of computational tools in therapeutic guidance and patient care. The panel also reflects on the importance of harmonisation, interdisciplinary collaboration, and real-world clinical implementation as the field continues to evolve. Alongside the future-facing conversation, the episode highlights how ESDIP is supporting the pathology community through education, global partnerships, accessible membership opportunities, and initiatives such as the ESDIP Academy. From residents and researchers to practicing pathologists and industry leaders, the discussion captures how the society is helping shape the future of pathology while creating opportunities for the next generation to get involved.

From Workflow Efficiency to Predictive Biomarkers: Eric Walk on the Future of AI Pathology

In this episode of the Pathology News podcast, Sidney Ocanagil-Tunstall speaks with Eric Walk about the evolving role of deep neural networks in digital pathology and how AI-assisted tools are beginning to reshape clinical diagnostics and drug development. Eric reflects on his career journey from diagnostic pathology into precision medicine and biomarker innovation, before exploring how AI is currently being deployed across pathology workflows, clinical trials, and translational research. The conversation covers digital transformation in pathology, workflow efficiency, predictive biomarkers, variability in clinical trials, and the growing role of AI-assisted decision support. The episode also explores PathAI’s work in MASH and inflammatory bowel disease, including FDA and EMA-qualified AI assist tools designed to improve biomarker scoring and endpoint assessment. Rather than focusing solely on diagnosis, the discussion highlights how computational pathology is enabling more structured histopathology data, improving reproducibility, and creating new opportunities for precision medicine and clinical research.